Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
248.1 USD | +1.95% |
|
+3.06% | +29.30% |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.30% | 30.78B | |
+16.00% | 44.44B | |
-9.67% | 37.99B | |
+37.46% | 37.75B | |
-8.64% | 27.38B | |
+12.42% | 26.17B | |
+44.33% | 14.15B | |
+33.61% | 12.59B | |
-7.03% | 11.28B | |
-13.89% | 10.47B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Transcript : Alnylam Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 15, 2024